Backs FY25 revenue view $61B-$64B, consensus $62.92B.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PFE:
- Pfizer’s Financial Outlook: Hold Rating Amidst Short-Term Challenges and Long-Term Potential
- Notable companies reporting before tomorrow’s open
- Pfizer call volume above normal and directionally bullish
- Eli Lilly, Pfizer, Amgen – Trump’s 25% Pharma Tariffs Could Drain $51B Annually
- ‘Regulatory Headwinds Set to Bite,’ Says Top Analyst on Novavax Stock (NVAX)
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue